Nanoparticle Vaccines against Viral Infections

Dear Colleagues,

Despite significant progress being made in the field of vaccine development, outbreaks of emerging pathogens and insufficient immunogenicity of some licensed vaccines are calling for novel technologies in rational vaccine design. In the last decade, nanoparticles of different origin (virus-like particles, exosomes, liposomes, polymers, inorganic nanoparticles, etc.) have been increasingly tested in various vaccine formulations in order to improve humoral and cellular immune responses. Modern genetic and biochemical tools have turned nanoparticle-based vaccines into a flexible platform for modulation of both strength and quality of the antiviral immune responses on demand.

The scope of this Special Issue is to bring together the latest scientific and technical developments made in the field of antiviral nanoparticle vaccines. I sincerely hope this exchange would contribute to the conception of novel nanovaccines with desirable properties.

This Special Issue is the 2.0 version of the Special Issue "Virus-Like Particle & Nanoparticle Vaccines against Viral Infections". You could access this issue at: https://0-www-mdpi-com.brum.beds.ac.uk/journal/vaccines/special_issues/Virus_Particle_Nanoparticle_Vaccines_Viral

Dr. Vladimir Temchura
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Virus-like particles
• Synthetic nanoparticles
• Nanoparticulate systems
• Administration routes for nanoparticle vaccines
• Functionalization of nanoparticles with antigens and adjuvants
• Therapeutic antiviral nanovaccines
• Prophylactic antiviral nanovaccines
• Modulation of the immune response.